Inherited macrothrombocytopenia with distinctive platelet ultrastructural and functional features

Thrombosis and Haemostasis

Volumn 83, Issue 1, 2000, Pages 35-41

  Rocca, Bianca ^b,c   Ranelletti, Franco O ^a   Maggiano, Nicola ^a   Ciabattoni, Giovanni ^a   De Cristofaro, Raimondo ^b   Landolfi, Raffaele ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b Unit of Respiratory Pathophysiology   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Actin; Function; Macrothrombocytopenia; Platelet; Platelet ultrastructure; Thromboxane; Tubulin

Indexed keywords

ACTIN; ADENOSINE DIPHOSPHATE; AUTOANTIBODY; COLLAGEN; RISTOCETIN; THROMBIN; THROMBOXANE A2; TUBULIN;

ADULT; ARTICLE; BLEEDING TIME; CASE REPORT; CELL ORGANELLE; CELL VACUOLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOSKELETON; FAMILY STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MACROPHAGE; MICROTUBULE; NEUTROPHIL; PHAGOCYTOSIS; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE SHAPE; THROMBOCYTE STRUCTURE; THROMBOCYTOPENIA; URINARY EXCRETION;

EID: 0033954271     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613753     Document Type: Article

References (28)

1. Rocca B, Laghi F, Zini G, Maggiano N, Landolfi R. Fechtner syndrome: report of a third family and literature review. Br J Haematol 1993; 85: 423-6.
2. Greinacher A, Mueller-Eckhardt C. Hereditary types of thrombocytopenia with giant platelets and inclusion bodies in the leukocytes. Blut 1990; 60: 53-60.
3. Parker RI, Bray GL, McKeown LP, White JG. Failure to mobilize intracellular calcium in response to thrombin in a patient with familial thrombocytopathy characterized by macrothrombocytopenia and abnormal platelet membrane complexes. J Lab Clin Med 1993; 122: 441-9.
4. Raccuglia G. Gray platelet syndrome: a variety of qualitative platelet disorder. Am J Med 1971; 51: 818-28.
5. Najean Y, Lecompte T. Genetic thrombocytopenia with autosomal dominant transmission: a review of 54 cases. Br J Haematol 1990; 74: 203-8.
6. Epstein CJ, Sahud MA, Piel CF, Goodman JR. Hereditary acrothrombocytopenia, nephritis and deafness. Am J Med 1972; 52: 299-310.
7. Noris P, Spedini P, Belletti S, Magrini U, Balduini CL. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings. Am J Med 1998; 104: 335-60.
8. Rocca B, Bellacosa A, De Cristofaro R, Della Ventura M, Maggiano N, Rumi C, Landolfi R. Wiskott-Aldrich syndrome: report of an autosomal dominant variant. Blood 1996; 87: 4583-43.
9. De Marco L, Mazzuccato M, Masotti A, Fenton II JW, Ruggeri ZM. Function of glycoprotein Ibα in platelet activation induced by α-thrombin. J Biol Chem 1991; 226: 23776-83.
10. Dixon R, Rosse W, Ebbert L. Quantitative determination of antibody in idiopatic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response. N Engl J Med 1975; 292: 230-6.
11. Landolfi R, De Cristofaro R, De Candia E, Rocca B, Bizzi B. Effect of fibrinogen concentration on the velocity of platelet aggregation. Blood 1991; 78: 377-81.
12. 2α in human urine. J Endocrinol Invest 1979; 2: 173-82.
13. Rocca B, Ciabattoni G, Tartaglione R, Cortelazzo S, Barbui T, Patrono C, Landolfi R. Increased thromboxane biosynthesis in essential thrombocythemia. Thromb Haemost 1995; 74: 1225-30.
14. 2 in human plasma and urine. Biochim Biophys Acta 1987; 918: 293-7.
15. White JG, Sauk JJ. The organization of microtubules and microtubule coils in giant platelet disorders. Am J Pathol 1984; 116: 514-22.
16. Sixma JJ, van der Berg A, Jockush BM, Hartwig J. Immunoelectron microscopic localization of actin, a-actinin, actin binding protein and myosin in resting and activated human blood platelets. Eur J Cell Biol 1989; 48: 271-81.
17. Hartwig JH. Mechanism of actin rearrangements mediating platelet activation. J Cell Biol 1992; 118: 1421-42.
18. Milton JC, Frojmovic MM, Tang SS, White JC. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS). Am J Pathol 1984; 114: 336-45.
19. Lipsky PE, Abramson SB, Crofford L, DuBois RN, Simon LS, van de Putte LBA. The classification of cyclooxygenase inhibitors. J Rheumatol 1998; 25: 2298-303.
20. Patrono C, Ciabattoni G, Pugliese F, Filabozzi P, Catella F, Davi G, Forni L. Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation 1985; 72: 1177-84.
21. Reilly I, FitzGerald GA. Inhibition of thromboxane formation in vivo and ex vivo: implication for therapy with platelet inhibitory drugs. Blood 1987; 69: 180-6.
22. 2 metabolites in man: identification of twenty urinary metabolites. J Biol Chem 1981; 256: 8384-93.
23. Patrono C, Ciabattoni G, Pugliese F. Pierucci A, Blair IA, FitzGerald GA. Estimated rate of thromboxane secretion into the circulation of normal humans. J Clin Invest 1986; 77: 590-4.
24. Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996; 87: 4925-36.
25. Tablin F, Castro M, Leven RM. Blood platelet formation in vitro. The role of the cytoskeleton in megakaryocyte fragmentation. J Cell Sci 1990; 97: 59-70.
26. Latimer P, Born GVR, Michal F. Application of light-scattering theory to the optical effects associated with the morphology of Wood platelets. Arch Biochem Biophys 1977; 180: 151-9.
27. Laffi G, Cinotti S, Filimberti E, Ciabattoni G, Caporale R, Marra F, Melani L, Grossi A, Carloni V, Gentilini P. Defective aggregation in cirrhosis is independent of in vivo platelet activation. J Hepatol 1996; 24: 436-43.
28. Davi G, Ferro D, Basili S, Iuliano L, Camastra C, Giammarresi C, Santarone S, Rocca B, Landolfi R, Ciabattoni G, Cordova C, Violi F. Increased thromboxane metabolites excretion in liver cirrhosis. Thromb Haemost 1998; 79: 747-51.